Celldex Therapeutics, Inc. (CLDX)
27.53
-1.40
(-4.84%)
USD |
NASDAQ |
Oct 16, 16:00
27.53
0.00 (0.00%)
After-Hours: 17:01
Celldex Therapeutics Price : 27.53 for Oct. 16, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 28.05 | 28.95 | 27.65 | 28.93 | 1.182M |
| Oct 14, 2026 | 28.49 | 28.73 | 27.68 | 27.84 | 1.044M |
| Oct 13, 2026 | 29.28 | 29.28 | 27.92 | 28.25 | 1.898M |
| Oct 12, 2026 | 29.61 | 30.02 | 28.99 | 29.43 | 596417.0 |
| Oct 09, 2026 | 29.04 | 30.26 | 28.88 | 29.89 | 992779.0 |
| Oct 08, 2026 | 30.07 | 30.10 | 28.63 | 29.30 | 3.950M |
| Oct 07, 2026 | 30.62 | 31.35 | 30.10 | 30.43 | 1.747M |
| Oct 06, 2026 | 32.68 | 32.68 | 30.85 | 31.00 | 1.768M |
| Oct 05, 2026 | 31.83 | 32.88 | 31.50 | 32.59 | 1.258M |
| Oct 02, 2026 | 32.26 | 32.54 | 30.98 | 31.65 | 2.406M |
| Oct 01, 2026 | 32.26 | 32.55 | 31.70 | 32.18 | 1.443M |
| Sep 30, 2026 | 31.71 | 32.76 | 31.45 | 32.41 | 2.503M |
| Sep 29, 2026 | 31.49 | 31.79 | 31.00 | 31.64 | 2.030M |
| Sep 28, 2026 | 31.06 | 32.15 | 30.38 | 31.49 | 1.824M |
| Sep 25, 2026 | 31.48 | 31.70 | 30.65 | 31.10 | 2.024M |
| Sep 24, 2026 | 31.48 | 31.66 | 30.59 | 31.48 | 2.298M |
| Sep 23, 2026 | 33.54 | 33.59 | 30.40 | 31.12 | 4.236M |
| Sep 22, 2026 | 36.60 | 38.39 | 30.39 | 33.51 | 12.89M |
| Sep 21, 2026 | 41.62 | 41.62 | 37.48 | 37.89 | 549513.0 |
| Sep 18, 2026 | 38.87 | 38.87 | 37.54 | 38.24 | 2.082M |
| Sep 17, 2026 | 39.47 | 40.66 | 38.92 | 38.98 | 1.279M |
| Sep 16, 2026 | 38.59 | 39.21 | 38.25 | 38.71 | 1.001M |
| Sep 15, 2026 | 39.00 | 39.19 | 37.74 | 38.51 | 686390.0 |
| Sep 14, 2026 | 37.40 | 39.42 | 37.27 | 39.18 | 1.000M |
| Sep 11, 2026 | 38.39 | 38.59 | 36.84 | 36.90 | 1.034M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Gilead Sciences, Inc. | 156.19 |
| ACADIA Pharmaceuticals, Inc. | 19.13 |
| Alnylam Pharmaceuticals, Inc. | 231.87 |
| Anika Therapeutics, Inc. | 20.01 |
| Savara, Inc. | 4.45 |
Price Related Metrics
| PS Ratio | 12079.88 |
| PEG Ratio | -0.1406 |
| Price to Book Value | 3.024 |
| Earnings Yield | -15.83% |
| Market Cap | 2.161B |
| PEGY Ratio | -0.1406 |